Scientists from the Institute of Human Virology (IHV) at the University of Maryland School of Medicine (UMSOM) this week proposed a new theory, based on the findings of three previously published studies, to improve the efficacy and safety of immunotherapy drugs. The theory calls for a new design for these drugs that would prevent side effects like life-threatening immune system reactions and enable a higher dose of the drug to be administered.
Image: https://www.umaryland.edu
{iframe}https://www.umaryland.edu/news/archived-news/december-2019/newspressreleaseshottopics/new-theory-for-cancer-immunotherapy.php{/iframe}